Defective influenza virus particles

Details for Australian Patent Application No. 2005303817 (hide)

International Classifications

Event Publications

21 June 2007 PCT application entered the National Phase

PCT publication WO2006/051069 Priority application(s): WO2006/051069

20 March 2008 Assignment before Grant

Erasmus University Medical Center Rotterdam (Erasmus MC); Solvay Pharmaceuticals B.V. The application has been assigned to Erasmus University Medical Center Rotterdam (Erasmus MC); Solvay Biologicals B.V.

10 June 2010 Application Accepted

Published as AU-B-2005303817

30 September 2010 Corrigenda

Applications Accepted - Name Index Under the name Erasmus University Medical Center Rotterdam (Erasmus MC); Solvay Biologicals B.V., Application No. 2005303817, under INID (71) correct the co-applicant name to Erasmus University Medical Center Rotterdam

7 October 2010 Standard Patent Sealed

20 September 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read Erasmus University Medical Center Rotterdam and Abbott Biologicals B.V. . Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.